1. Home
  2. AMBO vs TOVX Comparison

AMBO vs TOVX Comparison

Compare AMBO & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambow Education Holding Ltd.

AMBO

Ambow Education Holding Ltd.

N/A

Current Price

$2.87

Market Cap

8.1M

Sector

Real Estate

ML Signal

N/A

TOVX

Theriva Biologics Inc.

HOLD

Current Price

$0.21

Market Cap

7.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMBO
TOVX
Founded
2000
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1M
7.3M
IPO Year
2010
2006

Fundamental Metrics

Financial Performance
Metric
AMBO
TOVX
Price
$2.87
$0.21
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
23.3K
11.0M
Earning Date
08-05-2025
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.69
N/A
Revenue
$9,699,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.10
N/A
Revenue Growth
23.73
N/A
52 Week Low
$1.59
$0.17
52 Week High
$6.75
$2.03

Technical Indicators

Market Signals
Indicator
AMBO
TOVX
Relative Strength Index (RSI) 40.20 46.38
Support Level $2.70 $0.19
Resistance Level $3.00 $0.22
Average True Range (ATR) 0.33 0.02
MACD 0.02 0.00
Stochastic Oscillator 27.72 33.50

Price Performance

Historical Comparison
AMBO
TOVX

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Share on Social Networks: